The tremendous potential of solving the donor organ shortage with xenotransplantation of genetically engineered pigs is shadowed by the potential infection risks. Thus, if the xenotransplantation of pig tissues results in the activation of PERV viral replication, the risk of spreading this retrovirus to the human host is real, especially activated cells infiltrating a graft site under potent immunosuppression. That could result in an increased risk of leukemia or lymphoid tumors. In turn, if the transplant patient becomes infected there is also a potential of selecting and spreading a new variant of PERV adapted to the human host, first to immediate contacts and next to the public. Therefore, there is a critical need to advance our current understanding of the risk and biology of xenogeneic viral infection as part of a strategy for moving forward with clinical trials of xenotransplantation. The centerpiece for the present grant proposal is that we are the first group to clone the human receptors for PERV A. Therefore, the objectives of this proposal are to determine the expression of these receptors in human tissues as well as develop a transgenic mouse model expressing either or both the human PERV A receptors. If successful, this will be a major advance in the field allowing us to study the potential of PERV infection via the human receptor, compartmentalization, pathogenesis, viral adaptation impact of immunosuppression and risk of spread to uninfected animals.
Specific Aim #I : Determine the expression of the human PERV A receptors in human tissue compartments and explore activation-induced changes in expression, cellular compartmentalization and possible functional impact of the PERV A receptors and PERV A virus in lymphocytes.
Specific Aim #2 : Produce transgenic mice for both human PERV A receptors (Al/A2) and determine the incidence, compartmentalization, phenotype and risk of PERV infection in this novel small animal model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052349-02
Application #
6637755
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Koh, Crystal Y
Project Start
2002-05-15
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
2
Fiscal Year
2003
Total Cost
$407,620
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kremer, P H C; Koeleman, B P C; Pawlikowska, L et al. (2015) Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry 86:524-9
Kurian, S M; Williams, A N; Gelbart, T et al. (2014) Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant 14:1164-72
Dosanjh, Amrita; Robison, Elizabeth; Mondala, Tony et al. (2013) Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury. BMC Genomics 14:275
Mazari, Peter M; Argaw, Takele; Valdivieso, Leonardo et al. (2012) Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A. Virology 427:118-26
Nakorchevsky, Aleksey; Hewel, Johannes A; Kurian, Sunil M et al. (2010) Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 21:362-73
Lamere, Sarah A; St Leger, Judy A; Schrenzel, Mark D et al. (2009) Molecular characterization of a novel gammaretrovirus in killer whales (Orcinus orca). J Virol 83:12956-67
Kurian, Sunil M; Heilman, Raymond; Mondala, Tony S et al. (2009) Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 4:e6212
Marcucci, Katherine T; Argaw, Takele; Wilson, Carolyn A et al. (2009) Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry. Retrovirology 6:3
Marcucci, Katherine T; Martina, Yuri; Harrison, Frank et al. (2008) Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity. Virology 375:637-45
Gemeniano, Malou; Mpanju, Onesmo; Salomon, Daniel R et al. (2006) The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology 346:108-17

Showing the most recent 10 out of 12 publications